Oct 30 2023
Medical cannabis “is safe and highly effective for treating neuropathic pain and concomitant sleep disturbance”, states a new study. Titled Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases, the study was published in the peer-reviewed journal Medical Cannabis and Cannabinoids, and it was published …
Oct 30 2023
State Representative Eric Bell (D), along with a coalition of activists and industry leaders, has announced new legislation to reform the state’s marijuana laws. The New Georgia Project Action Fund has joined forces with State Representative Eric Bell (D) to announce the We Want All The S.M.O.K.E. (Spreading Marijuana Opportunities and Knowledge Everywhere) Campaign. The …
Oct 30 2023
According to new polling, nearly 60% of likely Ohio voters plan to vote “Yes” on Issue 2. The new PublicPolicyPolling survey found that 59% of those who are likely to vote in this month’s election are in support of Issue 2, which would legalize recreational marijuana for everyone 21 and older. “Issue 2 is a …
Oct 30 2023
A Massachusetts campaign seeking to legalize psychedelics has collected enough valid signatures to force the legislature to vote on their initiative. The nonprofit political committee Massachusetts for Mental Health Options says it has verified over 75,000 signatures from registered voters, more than the 74,574 needed to force the state’s legislature to consider the proposal. The …
Oct 29 2023
Legislation filed Friday in the New York Assembly “Prohibits roadside signage for the sale of cannabis or cannabis products on a highway, road, or other vehicular pathway”. Assembly Bill 8200 was filed by Assemblymember Scott Gray, and it has been assigned to the Assembly Economic Development Committee. The proposed law “establishes that a civil penalty …
Oct 28 2023
A new study published in the journal Pharmaceuticals found that “chronic CBG administration can provide at least 24 hours of antinociceptive effect” in an animal model of neuropathic pain. “Cannabigerol (CBG), derived from the cannabis plant, acts as an acute analgesic in a model of cisplatin-induced peripheral neuropathy (CIPN) in mice”, states the abstract of …
Oct 27 2023
31 bipartisan members of the US House of Representatives have sent a letter to the Drug Enforcement Administration (DEA) urging them to consider legalizing marijuana via descheduling it. In August the Department of Health sent a letter to the Drug Enforcement Agency (DEA) officially requesting marijuana be reclassified as a Schedule III drug under the …
Oct 27 2023
Psychemedics, a global leader in the drug screening industry, has “proudly” announced the launch of a “revolutionary” drug screening panel that removes marijuana and emphasizes fentanyl. According to a press release, this “groundbreaking offering will transform the way organizations safeguard their workplaces, shifting the spotlight from marijuana to the paramount threat of fentanyl.” Complemented by …
Oct 27 2023
At their Thursday meeting the Alabama Medical Cannabis Commission (AMCC) officially reset the licensing process for the new industry, rescinding all licenses and denials that have been awarded thus far. In June the AMCC awarded 21 companies with medical marijuana licenses. Due to litigation the commission voided these licenses in August and issued 24 new …
Oct 27 2023
According to a new study the marijuana compound cannabidiol (CBD) “decreased total seizures and seizure days compared to placebo when administered to dogs PO at 9 mg/kg/day.” Published in the Journal of Veterinary Internal Medicine, the study was conducted by researchers at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University. “Approximately 30% …
